Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



MDT Medtronic PLC's Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and Neuromodulation Segments

February 26, 2025
Medtronic PLC, a global leader in medical technology, recently announced its Q3 2025 earnings call highlights, showcasing strong growth in its cardiac and neuromodulation segments. The company reported impressive revenue growth, driven by innovative products and expanding market opportunities.

In the cardiac segment, Medtronic witnessed a significant increase in sales of its advanced cardiac devices, such as pacemakers and defibrillators. This growth can be attributed to the rising incidence of cardiovascular diseases and the increasing adoption of these life-saving devices by healthcare professionals worldwide.

Moreover, Medtronic's neuromodulation segment also experienced robust growth, driven by the successful launch of its revolutionary adaptive brain stimulation technology for Parkinson's disease. This breakthrough treatment has received FDA approval, further solidifying Medtronic's position as a pioneer in neurostimulation therapies.

The company's strong performance in these key segments is a testament to its commitment to innovation and its focus on meeting the evolving needs of patients and healthcare providers. With a diverse portfolio of products and a strong pipeline of new advancements, Medtronic remains well-positioned for continued growth in the medical technology sector.

Investors looking to capitalize on Medtronic's success and potential for future growth may consider consulting with professionals from Stocks Prognosis for expert analysis and forecasts on the movement of the company's stocks. Their comprehensive market research and insights can help investors make informed decisions and maximize their investment returns.

Disclaimer: The views and recommendations mentioned in this article are for informational purposes only and should not be construed as professional investment advice. Investing in stocks carries risks, and individuals should conduct their own research and consult with financial experts before making any investment decisions.

Find out how the MEDTRONIC PLC rate is expected to change

Get Forecast for MDT

Investor opinions & comments:

I'm impressed by Medtronic's commitment to innovation and their focus on advancing medical technology. It's exciting to see companies making advancements in life-saving devices and therapies
— from ChrisDavis at 03-01-2025 08:28
Is Medtronic overly reliant on the cardiac and neuromodulation segments? What is their strategy for diversification?
— from CashCaleb at 02-28-2025 21:33
I would be interested to see how Medtronic's success in these segments compares to their competitors. Is their growth outperforming the industry average?
— from CalebBishop at 02-28-2025 14:42
With their diverse portfolio and strong pipeline, Medtronic is well-positioned for continued growth. I have confidence in their ability to deliver innovative solutions for patients
— from SarahAllen at 02-27-2025 20:48
I'm skeptical about Medtronic's potential for future growth. Are there any regulatory risks or challenges they may face in the coming years?
— from RobertWhite at 02-27-2025 14:35
While Medtronic's growth sounds impressive, I wonder if it is sustainable. Will they continue to innovate and stay ahead of competitors in the long run?
— from WealthyWendy at 02-27-2025 10:32
I'm excited to see Medtronic's success in the neuromodulation segment. Their adaptive brain stimulation technology for Parkinson's disease has the potential to improve the lives of many patients
— from SavingsSam at 02-27-2025 05:56
Investing in Medtronic seems like a smart move, considering their impressive revenue growth and market opportunities. This is definitely a company to watch in the medical technology sector
— from AnnaDuncan at 02-26-2025 12:41
This is great news for Medtronic! Their growth in the cardiac and neuromodulation segments shows that their products are in high demand and meeting the needs of patients and healthcare providers
— from WealthyWanda at 02-26-2025 12:02
Medtronic's strong performance in the cardiac and neuromodulation segments is a testament to their leadership and expertise in the medical technology industry
— from AudreyRussell at 02-26-2025 10:28
If you want to leave a comment, then you need Login or Register





Other news for MDT

MDTMay 22, 2025QuantWave Successfully Achieves Price Target Forecast for MEDTRONIC PLC, Generating 4.54% Profit  ~1 min.

QuantWave, the automated forecasting platform, has successfully reached its price target forecast for the stock MEDTRONIC PLC, resulting in a profit of 4.54%....

MDTMay 19, 2025QuantWave Hits Bullseye with MEDTRONIC PLC Forecast, Investors Reap 4.93% Profit  ~2 min.

QuantWave, the cutting-edge automated forecasting platform, has once again demonstrated its prowess in predicting stock movements with remarkable accuracy....

MDTMay 1, 2025Medtronic Receives FDA Approval for Groundbreaking Defibrillation Lead  ~2 min.

Medtronic PLC, a global leader in medical technology, has recently received FDA approval for its revolutionary 4.7F defibrillation lead, the smallest-diameter lumenless lead available on the market....

MDTMarch 22, 2025Innovative Medical Device Company, Medtronic PLC, Surges in Popularity Among Investors  ~2 min.

Medtronic PLC (MDT) is gaining significant attention from investors due to its groundbreaking medical technology and long-term growth potential....

MDTMarch 21, 2025Medtronic plc MDT: Experts Recommend Buying Stocks for Long-Term Investment  ~1 min.

According to the renowned financial experts at Stocks Prognosis, Medtronic plc (MDT) is one of the best European stocks to buy for long-term investment....



Related news

FORDDecember 20, 2024Neuvotion Expands AI-Driven Neurotech Partnership and Secures Investment for NeuStim Launch  ~2 min.

Forward Industries, Inc., through its subsidiary IPS (Intelligent Product Solutions), has announced further expansion of its AI-driven neurotech partnership with Neuvotion....

MDTFebruary 25, 2025Medtronic reports strong growth in cardiac and neuromodulation segments in Q3 2025  ~2 min.

Medtronic PLC, a global leader in medical technology, has announced its financial results for the third quarter of fiscal year 2025....

ABTDecember 3, 2024Abbott Laboratories Develops New Breakthrough in Medical Technology  ~2 min.

Abbott Laboratories, a leading global healthcare company, has announced a groundbreaking innovation in medical technology....

MDTFebruary 27, 2025Medtronic plc MDT: Revolutionary Adaptive Brain Stimulation System for Parkinson's Disease Receives FDA Approval  ~1 min.

Medtronic, a leader in medical technology, has recently earned the U.S. FDA's approval for its groundbreaking adaptive deep brain stimulation system for individuals with Parkinson's disease....

FORDDecember 24, 2024FORD FORWARD INDUSTRIES, INC. Announces Exciting Partnership and Launch of Revolutionary Technology for Stroke and Spinal Cord Injury  ~2 min.

Neuvotion, a leading medical device company, has recently expanded its partnership with Intelligent Product Solutions (IPS) and successfully commercialized its innovative NeuStim technology....